AzTrials
AzTrials

Bone HealingNCT06711744

ISQ Differences Between Different Implants in Post-extraction Sockets

A study testing Implant stability quotient in people with Bone Healing and Implant Stability, run by University of Rome Tor Vergata at 1 site in Italy.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Two different implants will be used in post-extraction sockets and ISQ will be recorded monthly from insertion moment to 12 months of follow up to understand if ISQ can be affected by implant macro design Read more about this study

Who is it for?
Ages 18 to 99 yearsHealthy volunteers can take part
Conditions the study is for
Bone Healing, Implant Stability
What is being tested?
Implant stability quotient
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteItaly
Study dates
31 Jan 2025to 28 Feb 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients (at least 18 years old) presenting with failing tooth.
  • no recession of gingival contour of tooth to be extracted
  • no periodontal bone loss of neighboring teeth
  • no implants in neighboring teeth
  • class I extraction socket (intact buccal wall)
  • atraumatic extraction of the tooth with intact socket walls remaining.

Who cannot join

  • deep bite (severe II class)
  • systemic disease (diabetes, osteoporosis)
  • heavy smokers (more than 10 cigarettes/day)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Italy1 site, 1 recruiting
  • Paolo Carosi

    Rome, RM, 00133

    Paolo Carosi, PhD, 3277998699, carosipaolo29@gmail.com

    Recruiting

Other trials in Italy

About this study

Official title: Effect of Time and Local Factors on Hydrophilic Tissue Level Implants in Post-extraction Sites: a RCT

Two different implants will be used in post-extraction sockets and ISQ will be recorded monthly from insertion moment to 12 months of follow up to understand if ISQ can be affected by implant macro design

Being tested
Implant stability quotient

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Implant stability quotientDiagnostic test

    Screw a smart peg into the implant and record the values from a dedicated device

Study groups in NCT06711744
Study groupRoleWhat they receive
TISSUE LEVEL XActive comparatorImplants with aggressive macro design
Receives: Diagnostic Test: Implant stability quotient
TISSUE LEVEL CExperimentalImplants with less aggressive macro design
Receives: Diagnostic Test: Implant stability quotient

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. IMPLANT STABILITY QUOTIENT

    Values of risonance of implants taken by means of a dedicated device that translate the risonance of each implant into a number (0-99).

    Measured: Monthly from T0 (implant insertion) to T12 (12 months after implant placement)

Secondary outcomes (1)
  1. Insertion torque

    Mechanical resistance of the bone at implant placement

    Measured: At implant placement

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Dec 2024
  2. Study start31 Jan 2025
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion28 Feb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06711744
Sponsor's protocol ID
TLCVSTLX
Status last verified
Nov 2024
First submitted
21 Nov 2024
Last updated
28 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Carosi P, Laureti A, Alrmali A, Pinto A, Wang HL, Lorenzi C. Design Matters? Evaluating Implant Macro-Geometry in Immediate Implants: A Randomized Clinical Trial With Six-Month Interim Analysis. Clin Exp Dent Res. 2026 Oct;12(5):e70490. doi: 10.1002/cre2.70490.

    PubMed 42927630

Questions about this trial

What is this clinical trial studying?

A study testing Implant stability quotient in people with Bone Healing and Implant Stability, run by University of Rome Tor Vergata at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Paolo Carosi, PhD (+393277998699, paolo.carosi@alumni.uniroma2.eu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

IMPLANT STABILITY QUOTIENT (time frame: Monthly from T0 (implant insertion) to T12 (12 months after implant placement)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06711744, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Mar 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in